Skip to main content
SpringerLink
Log in

Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The blocking and stimulant potencies of (−)-pindolol and (+)-pindolol were estimated on right atria and tracheae of guinea pig. Blocking affinities were estimated for β-adrenoceptor subtypes by using several agonists. Binding affinities of (−)-pindolol and (+)-pindolol were also estimated for β-adrenoceptors labelled with 3H-(−)-bupranolol in membranes of ventricular myocardium and lung of guinea pig.

  1. 1.

    Both (−)-pindolol and (+)-pindolol caused tracheal relaxation with intrinsic activities of 0.3. The concentration-effect curve for (−)-pindolol exhibits a high-sensitivity and a low-sensitivity relaxant component; the curve for (+)-pindolol was nearly monophasic. The EC50's were (−log mol/l) 9.2 and 6.1 for (−)-pindolol and 7.6 for (+)-pindolol. Using subtype-selective blockers it was found that the relaxant effects of (+)-pindolol and those of the high-sensitivity component of (−)-pindolol are mediated through β 2-adrenoceptors. The low-sensitivity component of relaxation of (−)-pindolol was antagonized by β-blockers less than expected from their affinities for β-adrenoceptors.

  2. 2.

    Both (−)-pindolol and (+)-pindolol caused an increase of atrial beating rate with an intrinsic activity of 0.2. The concentration-effect curve of (−)-pindolol was biphasic; the curve of (+)-pindolol was monophasic. The EC50's were (−log mol/l) 9.1 and 7.0 for (−)-pindolol and 7.5 for (+)-pindolol. From the use of subtype-selective antagonists we conclude that the positive chronotropic effects of (+)-pindolol are mediated predominantly by β 2-adrenoceptors. On the other hand, the high-sensitivity component of the positive chronotropic effects of (−)-pindolol appears to be mediated predominantly through β 1-adrenoceptors, although β 2-adrenoceptors may also participate. The low-sensitivity component of the positive chronotropic effects of (−)-pindolol is resistant to blockade by subtype-selective antagonists at concentrations causing at least 98% β-adrenoceptor occupancy. Only high but nondepressant concentrations of non-selective (−)-bupranolol antagonized the low-sensitivity component of (−)-pindolol.

  3. 3.

    (−)-Pindolol antagonized the effects of several agonists to similar extent in both trachea and right atrium. (+)-Pindolol was less potent as antagonist of the relaxant effects of (−)-noradrenaline on trachea than against those of (−)-adrenalinc, (−)-isoprenaline and (±)-salbutamol. On right atrium (+)-pindolol antagonized non-selectively the positive chronotropic effects of (−)-isoprenaline, (−)-adrenaline and (−)-noradrenaline. The estimated blocking constant K B was (−log mol/l) 9.5–9.6 for (−)-pindolol; the K B's of (+)-pindolol were 6.7–7.2 for β 1- and 7.8 for β 2-adrenoceptors. The evidence is consistent with different steric characteristics of β 1- and β 2-adrenoceptors.

  4. 4.

    (−)-Pindolol and (+)-pindolol competed in a stereoselective manner with 3H-(−)-bupranolol for β-adrenoceptors of ventricle and lung. The affinity ratio of (−)-pindolol/(+)-pindolol was 80 in lung and 200 in ventricle, supporting the concept of different steric properties of β 1- and β 2-adrenoceptors.

  5. 5.

    3H-(−)-bupranolol labelled a ventricular site that was recognized with low affinity (−log mol/l K D=4.9) by (−)-pindolol. This low-affinity site may be involved in causing the low-sensitivity stimulant effects of (−)-pindolol.

  6. 6.

    The dissociation between blockade (high potency) and stimulation (low potency) observed with (−)-pindolol and racemic pindolol can be accounted by different receptor populations mediating blockade and stimulation of (−)-pindolol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58

    Google Scholar 

  • Bertholet A, Milavec M, Waite R, Schild HO (1981) A study of beta-adrenoceptors in the guinea pig. Post Med J 57 (Suppl I): 9–17

    Google Scholar 

  • Bearer CF, Knapp RD, Kaumann AJ, Schwartz TL, Birnbaumer L (1980) Todohydroxybenzylpindolol: Preparation, localization of its iodine to the indole ring, and characterization as a partial agonist. Mol Pharmacol 17:328–338

    Google Scholar 

  • Bilski A, Wale JL (1976) Two types of intrinsic sympathomimetic activity with β-adrenoceptor blocking drugs. Br J Pharmacol 56:36P

    Google Scholar 

  • Bilski A, Robertson HH, Wale JL (1979) A study of the relationship between cardiac β-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clin Exp Pharmacol Physiol 6:1–9

    Google Scholar 

  • Bilski A, Dorries S, Fitzgerald JD, Jessup R, Tucker H, Wale JL (1980) ICI 118,551, a potent β-adrenoceptors antagonist. Br J Pharmacol 69:292P

    Google Scholar 

  • Bilski A, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β 2-adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 55:430–437

    Google Scholar 

  • Blinks JR (1965) Convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757

    Google Scholar 

  • Brimblecombe RW, Duncan WAM, Durant GJ, Ganellin CR, Parsons ME, Black JW (1975) The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol 53:435–436P

    Google Scholar 

  • Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108

    Google Scholar 

  • Clark BJ, Bertholet A (1983) Effects of pindolol on smooth muscle. Gen Pharmacol 14:117–119

    Google Scholar 

  • Dixon WJ, Brown MB (1979) Biomedical computer programs. P series. University of California Press, Berkeley Los Angeles London

    Google Scholar 

  • Fozard JR, Mobarok Ali ATM (1978) Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 301:223–235

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York, pp 283–335

    Google Scholar 

  • Furchgott RF (1976) Postsynaptic adrenergic receptor mechanisms in vascular smooth muscle. In: Bevan JA (ed) Vascular neuroeffector mechanisms. 2nd Int. Symp. Odense. Karger, Basel, pp 131–142

    Google Scholar 

  • Hedberg A, Minneman KP, Molinoff PB (1980) Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther 213:503–508

    Google Scholar 

  • Jennrich RI, Sampson PF (1968) Application of stepwise regression to non-linear least squares estimation. Technometrics 10:63–67

    Google Scholar 

  • Kaumann AJ (1973) Adrenergic receptors of cardiac muscle. Two different mechanisms of beta-blockers as partial agonists. Int. Union of Biochemistry, Symposium No. 52, Acta Physiol Lat Am 23:235–236

    Google Scholar 

  • Kaumann AJ (1978) On spare β-adrenoceptors for inotropic effects of catecholamines in kitten ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 305:97–102

    Google Scholar 

  • Kaumann AJ (1983a) Cardiac β-adrenoceptors. — Experimental viewpoints. Z Kardiol 72:63–82

    Google Scholar 

  • Kaumann AJ (1983b) A classification of heart serotonin receptors. Naunyn-Schmiedeberg's Arch Pharmacol 322:R42

    Google Scholar 

  • Kaumann AJ (1983c) Yohimbine and rauwolscine inhibit 5-hydroxy-tryptamine-induced contraction. Naunyn-Schmiedeberg's Arch Pharmacol 323:149–154

    Google Scholar 

  • Kaumann AJ, Birnbaumer L (1974) Characteristics of the adrenergic receptor coupled to adenylyl cyclase. Stereospecifity for ligands and determination of apparent affinity for beta blockers. J Biol Chem 249:7874–7885

    Google Scholar 

  • Kaumann AJ, Birnbaumer L, Wittmann R (1978) Heart β-adrenoceptors. In: O'Malley BW, Birnbaumer L (eds) Hormone receptors, vol 3, Academic Press, New York, pp 133–177

    Google Scholar 

  • Kaumann AJ, Lemoine H (1978) Vergleich der Affinitäten von Bupranolol and seinen Metaboliten mit denen anderer β-Rezeptor Hemmer. In: Rahn KH, Schrey A (eds) Betablocker. Urban-Schwarzenberg, München, pp 4–8

    Google Scholar 

  • Kaumann AJ, Blinks JR (1980a) Stimulant and depressant effects of β-adrenoceptor blocking agents on isolated heart muscle: A positive inotropic effect not mediated through adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 311:205–218

    Google Scholar 

  • Kaumann AJ, Blinks JR (1980b) β-Adrenoceptor blocking agents as partial agonists in isolated heart muscle. Naunyn-Schmiedeberg's Arch Pharmacol 311:237–248

    Google Scholar 

  • Kaumann AJ, Lemoine H (1983) Large discrepancies between membrane binding and blocking affinities in tissues for antagonists that select β-adrenoceptor subtypes but not for nonselective antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 324:R66

    Google Scholar 

  • Kaumann AJ, Lemoine H (1984) Direct labeling of β 1-adrenoceptors. Comparison of binding potency of 3H-(−)-bisoprolol with blocking potency of (−)-bisoprolol in kitten heart. Naunyn-Schmiedeberg's Arch Pharmacol (submitted for publication)

  • Kaumann AJ, Morris TH, Birnbaumer L (1979) A comparison of the influence of N-isopropyl and N-tert. butyl substituents on the affinity of ligands for sinoatrial β-adrenoceptors in rat atria and β-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 307:1–8

    Google Scholar 

  • Kaumann AJ, McInery DP, Gilmour DP, Blinks JR (1980) Comparative assessment of β-blocking agents as simple competitive antagonists in isolated heart muscle. Similarity of inotropic and chronotropic potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236

    Google Scholar 

  • Lemoine H, Kaumann AJ (1978) The affinity of carazolol for myocardial and tracheal β-adrenoceptors activated by (−)-isoprenaline. Naunyn-Schmiedeberg's Arch Pharmacol 302: R53

    Google Scholar 

  • Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144

    Google Scholar 

  • Lemoine H, Kaumann AJ (1983) A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope unity. Naunyn-Schmiedeberg's Arch Pharmacol 322:111–120

    Google Scholar 

  • Lemoine H, Ehle B, Kaumann AJ (1984) Direct labeling of β 1-adrenoceptors with 3H-ICI 118,551. Comparison of binding potency and blocking potency with a new statistical method. Naunyn-Schmiedeberg's Arch Pharmacol (submitted for publication)

  • Maguire ME, Wiklund RA, Anderson HJ, Gilman AG (1976) Binding of [125]iodohydroxybenzylpindolol to putative β-adrenergic receptors of rat glioma cells and other cell clones. J Biol Chem 251:1221–1231

    Google Scholar 

  • Manalan AS, Besch HR Jr, Watanabe AM (1981) Characterization of [3H] (±)-carazolol binding to β-adrenergic receptors. Circ Res 49:326–336

    Google Scholar 

  • Marano M, Kaumann AJ (1976) On the statistic of drug-receptor constants for parrtial agonists. J Pharmacol Exp Ther 198: 518–525

    Google Scholar 

  • Middlemiss DN, Buxton DA, Greenwood DT (1981) Betaadrenoceptor antagonists in psychiatry and neurology. Pharmacol Ther 12:419–437

    Google Scholar 

  • Morris TH, Kaumann AJ (1984) Different steric characteristics of β 1- and β 2-adrenoceptors. Naunyn-Schmiedberg's Arch Pharmacol 327:176–179

    Google Scholar 

  • Morris TH, Sandrock K, Kaumann AJ (1981) 3H-(−)-Bupranolol, a new β-adrenoceptor radioligand: Characterization of its binding to kitten heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25

    Google Scholar 

  • Nahorski SR (1981) Identification and significance of betaadrenoceptor subtypes. Trends Pharmacol Sci 2:95–98

    Google Scholar 

  • Nahorski SR, Willcocks AL (1983)_Interactions of β-adrenoceptor antagonists with 5-hydroxytryptamine receptor subtypes in rat cerebral cortex. Br J Pharmacol 78:107P

    Google Scholar 

  • O'Donnell SR, Wanstall JC (1979) The importance of choice of agonist in studies designed to predict β 1:β 2 adrenoceptor selectivity of antagonists from pA2 values on guinea-pig trachea and atrium. Naunyn-Schmiedeberg's Arch Pharmacol 308: 183–190

    Google Scholar 

  • O'Donnell SR, Wanstall JC (1980a) Are the pA2 values of selective β-adrenoceptor antagonists valid, when obtained on guineapig tracheal preparations contracted with carbachol? J Pharm Pharmacol 32:413–416

    Google Scholar 

  • O'Donnell SR, Wanstall JC (1980b) Evidence that ICI 118,551 is a potent, highly beta2-selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissues. Life Sci 27:671–677

    Google Scholar 

  • Paton WDM, Rang HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea pig in relation to acetylcholine receptors. Proc Roy Soc Ser B (London) 163:1–44

    Google Scholar 

  • Trendelenburg U (1960) The action of histamine and 5-hydroxy-tryptamine on isolated mammalian atria. J Pharmacol Exp Ther 130:450–460

    Google Scholar 

  • Trendelenburg U (1968) The effect of cocaine on the pacemaker of isolated guinea-pig atria. J Pharmacol Exp Ther 161:222–231

    Google Scholar 

  • Wächter W, Münch U, Lemoine H, Kaumann AJ (1980) Evidence that (+)-bupranolol interacts directly with myocardial β-adrenoceptors. Control of optical purity with differential thermal analysis. Naunyn-Schmiedeberg's Arch Pharmacol 313:1–8

    Google Scholar 

  • Waite R (1978) Activité sympathomimétique intrinsèque des bêtabloquants. Nouv Press Med 7:2707–2709

    Google Scholar 

  • Walter M, Lemoine H, Kaumann AJ (1982) Dissociation between stimulation and blockade (DSB) with optical isomers of pindolol on trachea and heart. The role of β-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 321:R21

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lehrstuhl für Klinische Physiologie, Physiologisches Institut der Universität Düsseldorf, Universitätsstraße 1, D-4000, Düsseldorf 1, Federal Republic of Germany

    Michael Walter, Horst Lemoine & Alberto Julio Kaumann

Authors
  1. Michael Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Horst Lemoine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Julio Kaumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walter, M., Lemoine, H. & Kaumann, A.J. Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 327, 159–175 (1984). https://doi.org/10.1007/BF00500912

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500912

Key words

Search

Navigation